The Biological Activity of 3-O-Acetyl-11-keto-β-Boswellic Acid in Nervous System Diseases

Neuromolecular Med. 2022 Dec;24(4):374-384. doi: 10.1007/s12017-022-08707-0. Epub 2022 Mar 18.

Abstract

Frankincense is a hard gelatinous resin exuded by Boswellia serrata. It contains a complex array of components, of which acetyl-11-keto-beta-boswellic acid (AKBA), a pentacyclic triterpenoid of the resin class, is the main active component. AKBA has a variety of physiological actions, including anti-infection, anti-tumor, and antioxidant effects. The use of AKBA for the treatment of mental diseases has been documented as early as ancient Greece. Recent studies have found that AKBA has anti-aging and other neurological effects, suggesting its potential for the treatment of neurological diseases. This review focuses on nervous system-related diseases, summarizes the functions and mechanisms of AKBA in promoting nerve repair and regeneration after injury, protecting against ischemic brain injury and aging, inhibiting neuroinflammation, ameliorating memory deficits, and alleviating neurotoxicity, as well as having anti-glioma effects and relieving brain edema. The mechanisms by which AKBA functions in different diseases and the relationships between dosage and biological effects are discussed in depth with the aim of increasing understanding of AKBA and guiding its use for the treatment of nervous system diseases.

Keywords: 3-O-Acetyl-11-keto-β-boswellic acid; Application potential; Biological activity; Nervous system diseases; Therapeutic mechanism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Boswellia*
  • Humans
  • Nervous System Diseases* / drug therapy
  • Plant Extracts / pharmacology
  • Resins, Plant
  • Triterpenes* / pharmacology
  • Triterpenes* / therapeutic use

Substances

  • acetyl-11-ketoboswellic acid
  • Plant Extracts
  • Triterpenes
  • Resins, Plant